TNPSC Thervupettagam

Vaccine against IBR

October 3 , 2025 13 hrs 0 min 17 0
  • India’s first indigenously developed glycoprotein E (gE) deleted DIVA marker vaccine against infectious bovine rhinotracheitis (IBR) was launched recently.
  • The vaccine named Raksha-IBR will address infertility, abortions and reduced milk productivity linked to the disease.
  • IBR is endemic in India and caused by Bovine Herpes Virus (BHV-1).
  • The disease is transmitted through the aerosol route and affects the reproductive systems.
  • It is also transmitted by semen from bulls to milch animals.
  • Infertility, abortions and lower milk productivity are some of the major impacts of the disease.
  • There is no vaccine available in India and there is no specific treatment against this disease thus far.

 

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories